27/01/2017
We are delighted to announce that Envision Pharma Group have acquired Curo Consulting Ltd ("Curo"), a global Pharma Market Access consultancy whose services are supported by innovative HEOR and Market Access software solutions. These include LENS™ (Literature and Evidence Navigation System) and Evidence Navigator™ − purpose-built technologies that will augment Envision’s range of industry-leading technology solutions. See the full press release at http://bit.ly/2k4GqUX
Envision Pharma Group Corporate Website